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ABSTRACT
Gay and bisexual men infected with human immunodeficiency virus (HIV) comprise a sizeable,
medically vulnerable population. Depression is the most commonly experienced mental health
disorder affecting this group of people, lending itself to a host of risks associated with
depression. As screening of depression in this population can be challenging, it is vital that
clinicians have the best available tools and guidelines to detect depressive symptomology. This
focused, comprehensive review of the literature examined current data describing the clinical
instruments used to detect depressive symptoms in HIV-infected gay and bisexual men. The aim
of this analysis was to seek out which instruments were the most widely and successfully
employed for this population. An initial search using EBSCOhost and associated databases
CINAHL, MEDLINE, PsycINFO, and Health and Psychosocial Instruments alongside inclusion
and exclusion criteria found 1,899 articles. Results were narrowed using additional inclusion and
exclusion criteria and relevancy, yielding a total of 13 articles for review. The findings of this
review suggest screening of depressive symptoms in HIV-infected gay and bisexual men was
most successful using the CES-D, the BSI-18, and the BDI. Health care providers should have an
understanding of the importance in assessing this population for depression and have access to
the best possible tools to do so.
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Introduction
Background and Significance
Human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system
causing severe immunocompromisation and susceptibility to various sequelae (Mulryan, 2010).
The function of a retrovirus is to infect a host cell through injection of ribonucleic acid (RNA);
which, through a series of cellular processes, becomes deoxyribonucleic acid (DNA) (Mulryan,
2010). This process is what allows HIV to commandeer healthy cells and use them to create
“daughter” cells for further distribution throughout the host. HIV is transmitted during exposure
to infected body fluids allowing the virus to move from person to person. The infected body
fluids with the highest concentrations of HIV are blood, semen, vaginal secretions, colostrum,
and cerebrospinal fluid (Mulryan, 2010). Transmission is defined by the infectious body fluid of
origin and is comprised of three main routes: sexual practices, contact with infected blood, and
vertical transmission from mother to fetus or mother to a breastfeeding child (Mulryan, 2010).
According to the Centers for Disease Control and Prevention (CDC), minority groups are
at highest risk for developing HIV infection. These include: gay men (men with same-sex sexual
behavior), bisexual men (men with same-sex and opposite-sex sexual behavior), IV drug users,
sex workers, prison populations, and economically disadvantaged individuals. This can be
explained by lack of access to testing, lack of regular medical care, lack of preventative measures
such as condoms or pre-exposure prophylaxis (PrEP), substance abuse, unstable housing, lack of
employment, and mental health disorders such as depression (Blank et. al, 2014).
Literature indicates that depression is reported as the most common mental health
diagnosis for people living with HIV/AIDS (PLWHA); it is as much as 1.99 times more

prevalent than in HIV-negative persons (Sherr et. al, 2011). Furthermore, 22 to 54 percent of
PLWHA in the United States reportedly experience depression and depressive symptoms. There
is significant evidence to suggest that infection with HIV may influence the development of
depression through a multifactorial process, including factors such as societal stigma, felt stigma
(the awareness of discrimination from external sources), necessary adherence to a lifelong
medication regimen, lack of familial or social support and changes in body image related to
disease progression (Sherr, Clucas, Harding, Sibley, & Catalan, 2011). Additionally, there is
evidence to suggest that depression acts as a precursor to the development of HIV through
suppressing immune functioning prior to infection and potentiating risk factors of transmission
behaviors. Some of these behaviors include not adhering to prescribed drug regimen, engaging in
unprotected sexual intercourse, engaging with higher numbers of sexual partners, and abusing
substances.
The vast majority of PLWHA are minorities; as such, they experience a significant
amount of stigmatization. This stigmatization of PLWHA, particularly against gay and bisexual
men, is defined as devaluation due to discrimination, labeling, attributing damaging qualities,
and separation from society (Ramirez-Valles, Molina, & Dirkes, 2013). According to RamirezValles and colleagues (2013), attribution theory is a framework that describes how negative
labels are incurred on PLWHA and how these labels stem from the belief that HIV-infected
people are deserving of their diagnosis. Individuals attribute the cause of a characteristic to an
inference about the characteristics’ responsibility. Once an inference is developed an emotional
reaction occurs later evolving into a behavioral response, such as separation (Ramirez-Valles et.
al, 2013). An example of attribution theory in this study might be: an outside individual views a
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gay man infected with HIV as being responsible for his diagnosis and subsequently separates
from him. As a result of blame and stigmatization, HIV positive individuals experience societal
isolation, guilt about their status, anxiety, and suicidality (Sivasubramanian et. al, 2011).
Additionally, this contributes greatly to the development and severity of depression and
depressive symptomology.
Depression is a highly debilitating illness; and its emergence is linked to diminished
quality of life and highly critical outcomes. These include: diminished adherence to highly active
antiretroviral therapy (HAART) and further disease progression to Acquired Immunodeficiency
Syndrome (AIDS). AIDS is characterized by the CDC as a CD4 count below 200 cells/mm3 or
development of specific opportunistic infections, including candidiasis of the pulmonary system,
coccidiodomycosis, and Cryptococcus bacterial infections (CDC, 2012). Depressed PLWHA
might have difficulty with the minutiae of a drug regimen (Gruber, Sorenson, & Haug, 2007).
Factors identified as being associated with this include coordinating movement to take
medications, difficulty timing correct dosage, and forgetting or skipping doses. Depression
seems to cause individuals to recall adherence problems more frequently and report them more
freely (Gruber et. al, 2007). This tendency to fixate on mistakes, such as forgetting doses, is an
important factor to account for in researching depression in HIV-infected gay and bisexual men.
A challenging aspect of living with HIV is maintaining strict adherence to its associated
medication regimen- typically in the form of highly active anti-retroviral therapy (HAART)- to
suppress viral load, decrease risk of transmission, and prevent further progression to AIDS
(Gruber, Sorensen, & Haug, 2007). Ninety-five percent of the prescribed dose must be taken in
order to suppress viral load effectively. Due to the necessity for near perfect compliance,
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mutation of HIV with consequential resistance is a concern (Fisher et. al, 2006). HAART is
considered a complex regimen as it involves taking three or more medications at several times
over the course of the day. Additionally, it is not free from adverse effects that affect desire, and
ability, to take the medication. According to Gruber and colleagues (2007), there are major
barriers to HAART adherence. These include: 1) variables in medication (e.g. adverse effects),
2) patient variables (e.g. psychosocial problems), 3) patient-health care provider relationship
variables, and 4) system of care variables. The second defined barrier (patient variables) is
pertinent to the discussion about how depression qualifies as a significant psychosocial barrier to
adhering to a HAART medication regimen (Gruber et. al, 2007).
Depression has the ability to increase risk-taking behavior and reduce adherence to
medications. Its development in PLWHA can contribute to severe alterations in immune
functioning. These alterations include reduced natural killer (NK) cell levels and impaired
ability of lymphocytes to proliferate (Alciati, Gallo, Monforte, Brambilla, & Mellado, 2007).
Deficiency of NK cells contribute considerably to immune decline by reducing total natural
immunity. A finding that bolsters the need to identify depression early, particularly in PLWHA,
is that antiretroviral therapies (including HAART) do not improve the reductions in NK cells
related to depression. In order to maintain an appropriate viral load and reduce rates of
mortality, PLWHA need to maintain the highest levels of immune functioning, which may not be
possible with diminished NK cell levels (Alciati et. al, 2007).
The formation of depression is multifactorial regardless of population; however, in each
at-risk population the factors that contribute to its formation are unique to that group of people
and their experiences. In HIV-infected gay and bisexual men, depression and depressive
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symptoms are related to factors such as sexuality (social and internalized homophobia), felt
stigma, abuse of drugs and alcohol, living with HIV, the implications of the HIV epidemic, body
image, social isolation, loss of family and friends- either through disease progression or through
separation (Körner et. al, 2008) Detection of depression in this population is complicated by the
overlap in symptoms of depression and HIV/AIDs. Somatic symptoms of depression are defined
in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) as significant weight
loss, sleep disorders, psychomotor agitation or suppression, fatigue, feelings of worthlessness,
diminished ability to concentrate, and suicidality (American Psychiatric Association, 2013).
The somatic symptoms of HIV generally mimic the symptoms listed above, often
confounding the health care providers of these patients. There are four recognizable situations
discussed by Körner and colleagues (2008) that complicate the process of defining depression in
HIV-infected gay and bisexual men. First is the gap between recognition of depressive symptoms
and the health care provider’s ability to match a patient’s symptoms to the psychiatric
designations needed for a true diagnosis. Second is the reluctance of many to accept a diagnosis
of depression, particularly when only experiencing somatic symptoms. Third is the hesitance
experienced when a standardized instrument detects depressive symptoms or makes a diagnosis
of depression but the individual perceives his or her experiences to be a result of poverty, loss of
jobs, unstable housing, social isolation, or the diagnosis of HIV. The fourth situation that
complicates this process is determining if depression occurred primary to an HIV diagnosis or
secondary to an HIV diagnosis. In the instances of depression occurring primary to HIV, the
patient may have experienced symptoms or received a diagnosis prior to being diagnosed with
HIV. In the instances of depression occurring secondary to HIV, the patient may be experiencing
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symptoms as a result of: the diagnosis itself, felt stigmatization, or side effects from antiretroviral
therapies (Körner et. al, 2008)
The CDC estimates prevalence of HIV in the United States alone at 1,218,400 people,
with an incidence rate of 50,000 new infections each year (CDC, 2015). Suffering from mental
health problems (i.e. depression, anxiety, and suicidality) and adverse social conditions may
produce significantly enhanced vulnerability to infection with HIV. These are known as
syndemics and may affect an individual or population such as in gay and bisexual men
(Sivasubramanian et. al, 2011). Because depression is the most significant mental health concern
affecting HIV-infected individuals, screening for depression is a highly-indicated aspect of the
routine care of PLWHA. Screening of depression in this population can potentiate means for
treatment, improve health-protective behavior, enhance quality of life, and ameliorate rates of
mortality (Sherr, Clucas, Harding, Sibley & Catalan, 2011). Having an understanding of these
characteristics is important in tailoring interventions and treatments to improve adherence to
medications, increase access to mental health counseling, and reduce stigmatization.
Purpose
The purpose of this comprehensive review of the literature is to: 1) identify the
instruments most commonly used in the detection of depression in HIV-infected, adult gay and
bisexual men; 2) examine which of the identified tools have the highest efficacy in diagnosing
depression in this population; and 3) report the commonly cited strengths and weaknesses of
these instruments. Additionally, this review will provide a window into a sampling of available
clinical instruments used to diagnose depression in this population while providing rationales for
the importance of a strong screening instrument with suggestions for further research.
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Methods
An initial literature review search was performed using research databases accessed
through EBSCOhost. These included CINAHL Plus with Full Text, MEDLINE, PsychINFO, and
the Health and Psychosocial Instruments. Key terms used in the initial search included: (MH
"Human Immunodeficiency Virus") OR HIV OR "HIV-infected patient" OR HIV/AIDs OR
"Human Immunodeficiency Virus") AND (anxiety or depress*) AND (men or male) AND
(stigma* or shame or ridicule or prejudice* or stereotype*) AND instrument*. This search
yielded n = 195 articles. Upon review of these articles, abstracts, and research aims, the number
of accepted results was further reduced to n = 88 articles. These 88 articles were hand reviewed
for relevance; 56 were excluded for not fully meeting inclusion criteria, and 42 remained. A last
more detailed review was performed, excluding more articles due to lack of fit in this thesis.
Finally, 15 articles remained for inclusion into this work.
The results were limited for inclusion by English language, evidence-based practice,
being peer-reviewed, and using research instruments, questionnaires, or scales. Articles were
excluded from the search if they did not relate to adult populations (operationalized as being 18
years and older), HIV seropositive individuals, and depression or depressive symptomology. An
important note to make is the presence of HIV seropositive women and Trans* women in several
of the articles selected for inclusion. For the purposes of this literature review, however, the only
data considered for inclusion and discussion is that pertaining to depression in HIV-infected gay
and bisexual men.
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Discussion
Findings
Upon analysis of the literature, this study revealed some of the most commonly used
clinical instruments in HIV-infected gay and bisexual men with analysis of their efficacy in this
population. In Sherr and colleagues (2011) systematic review, 1,015 articles were generated with
90 studies included for analysis. Of the 90 articles, 58 addressed only HIV-infected gay and
bisexual men with emphasis on the challenges of detecting depression in this population (Sherr,
2011). The final 32 articles included in the systematic review addressed both HIV-infected gay
and bisexual men in addition to other HIV-infected adult populations. The articles included in
the Sherr study (2011) incorporated depression with other outcomes: anxiety, coping, quality of
life (QOL), fatigue, smoking, immunological measures, adherence to medication, adverse effects
of medications, HIV progression, and risk-taking behaviors. As noted throughout, there is a
significant overlap between somatization of depression and the experienced somatic symptoms
of HIV requiring clinicians to incorporate instruments that assess the “other outcomes” of
depression.
Twenty-one standardized instruments were analyzed in the above systematic review to
detect depression. As there is an abundance of clinical instrumentation used in the detection and
diagnosis of depression, this study focused on the five most commonly used tools from this
systematic review in addition with several tools from separate articles. The five most common
tools from the systematic review include the Beck Depression Inventory (BDI), the Hamilton
Depression Rating Scale (HAM-D), the Center for Epidemiological Studies Depression Scale
(CES-D), the Profile of Mood States (POMS) depression subscale, and the Clinical Global
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Impression (CGI). A feature typical to all of the studied literature is the comparison to the Mini
International Neuropsychiatric Interview (MINI) for efficacy.
The MINI is a brief, structured interview developed to detect the 16 major psychiatric
disorders within Axis I of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV).
Importantly, studies that incorporate the MINI indicate high validity and reliability in detecting
major depressive episodes, dysthymia, and suicidality (Sherr et. al, 2011). The MINI is
considered the gold standard in detecting depressive symptoms in all populations; however, it
does not consider chronic illness- such as HIV/AIDS. This leads to difficulty in differentiating
between the somatic symptoms of depression and HIV and lends itself to the need to determine a
screening tool that is most effective for HIV-infected gay and bisexual men.
Sherr and colleagues (2011) determined that the prevalence of depression in HIVinfected adults is around 51.6%. However, the true prevalence of depression in HIV-infected gay
and bisexual men is difficult to determine due to the use of different screening instruments and
the potential for persons to keep their sexual orientation hidden from their healthcare provider
(Körner et. al, 2008). For the purposes of this study, the prevalence rates of depression
determined by each screening instrument were compared to the average prevalence of depression
in HIV-infected adults (51.6%). The results were then generalized with the intention of
establishing a correlation between the instrument used and its efficacy in detecting depression.
Additionally, several of the studies reviewed made concerted efforts to control for the somatic
items that often skew the results of screenings. This occurs through the inclusion of additional
analyses with subscales that do not include somatic items. For example, the BDI includes
subscales specifically addressing depression (BDI Affective and BDI Cognitive/Affective). This
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is typically used in addition to the standard BDI to better grasp the affective aspects of
depression, rather than the somatic (Sherr et. al, 2011).
The BDI was cited 30 times in the systematic review (its subscales were cited 13 times).
It was used with various cut-off scores meaning each researcher established a statistical
prevalence after a certain number of questions were answered per the inventory. For instance, a
study with sample size of n = 299 HIV-infected gay and bisexual men determined a diagnosis of
moderate or severe levels of depressive symptoms could be accurately identified in 71% of the
sample after 16 or more questions were answered. Over the 30 instances of its use, the average
prevalence of depression determined by the BDI was 46.7% (Sherr et. al, 2011).
The HAM-D was cited 20 times in the systematic review and its subscales were cited 11
times. As with BDI, the HAM-D was used with varying cut-off scores, however, it determined
the average prevalence of depression was 49%. The CES-D was cited 19 times throughout the
review and it determined the average prevalence of depression as 49.4%. The POMS
Depression-Dejection subscale is cited 15 times throughout the systematic review and
determined the average prevalence of depression to be 36.2%. The CGI is cited 14 times
throughout the review and determined the average prevalence of depression to be 56.4% (Sherr
et. al, 2011).
An additional instrument from articles beyond the Sherr and colleagues (2011) systematic
review included use of the Brief Symptom Inventory-18 (BSI-18). The BSI-18 is an 18-question
screening tool for psychiatric distress, anxiety, depression, and somatization. The BSI-18 was
validated against the MINI and accurately described depression and depressive symptoms in N =
150 HIV-infected gay and bisexual men, 62% (n = 93) (Sivasubramanian et. al, 2011). In
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addition to assessing the efficacy of the BSI-18 through validation with the MINI, the instrument
incorporated contributing factors to distress, particularly those relevant to minority populations
with HIV such as: homelessness, substance abuse, and disrupted social support
(Sivasubramanian et. al, 2011).
In an attempt to determine whether the length of time needed to complete a screening
made a significant difference in results, researchers compared three clinical instruments with
their shortened form or their subscale. Literature indicates that long depression screening tools
and those requiring an interview between the health care provider and patient were often left unadministered or incomplete (Akena, Joska, Obuku, & Stein, 2013). This particularly in HIVinfected individuals; required multiple follow-up appointments and screenings.
A study performed by Akena and colleagues (2013) tested the validity of two brief scales
(and their shortened counterparts) to a long depression-screening instrument for PLWHA. These
included 1) the Patient Health Questionnaire-9 (PHQ-9) and its shortened version the PHQ-2; 2)
the Kessler-10 (K-10) and its shortened version the K-6; and 3) the CES-D (also mentioned by
Sherr et. al, 2011). The MINI was used as the standard to compare validity and efficacy in
detecting depression. The PHQ-9 measures depressive symptoms and their reported severity on a
Likert-type scale and focuses on the nine criteria for diagnosis of depressive disorders per the
DSM IV (Akena et. al, 2013).
When compared to the MINI, the PHQ-9 was able to correctly identify depression
89.36% of the time in this population with a sensitivity of 91.67% and specificity of 89.02%
(Akena et. al, 2013). The K-10 was able to correctly identify depression 74.7% of the time with
sensitivity of 83.33% and specificity of 72.37% (Akena et. al, 2013). Finally, the CES-D was
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able to correctly identify depression 82.95% of the time with a sensitivity of 88.95% and a
specificity of 81.43 % (Akena et. al, 2013). The overall results of the study indicate that the
shortened questionnaires (PHQ-2 and K-6) experienced decreased sensitivity and specificity as
well as a severely diminished ability to correctly identify depression. Additionally, it showed that
the PHQ-9 was the most effective in determining depressive symptoms in HIV-infected gay and
bisexual men.
Limitations
Determining the efficacy of the clinical instruments in this study was limited by several
factors. A potential threat to the generalizability of the study is that many of studies reviewed
had smaller sample sizes. This may have been brought about by fear of revealing sexuality to
providers, lack of access due to socio-demographics and socio-economics, and unwillingness to
fully complete screenings (by both health care providers and patients). Additionally, a great deal
of the literature included for analysis incorporated HIV-infected gay and bisexual men from
high-income countries such as the United States or United Kingdom. This creates a gap in the
understanding of this population from low-income and developing countries.
Further factors limiting discernment of efficacy were the 1) inability to discern baseline
depression from depression secondary to HIV and 2) the inability to distinguish between
somatization of depression versus HIV symptomology/disease progression. This was researched
in several of the studies; however, there was no singular instrument used to address these limits.
Instead, use of a primary screening tool with follow up subscales and interviews was necessary.
A dilemma with this process was the inability or unwillingness of health care providers and
patients to complete several screenings and interviews. This may have been a product of time
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constraints on medical visits in primary care settings or a function of somatic disease sequelae in
the patient. Thus, many of the studies included in this analysis themselves noted significant
participation limitations.
Future Research and Impact on Clinical Practice
Health care providers should continue to use validated instruments to detect/diagnose
depression in HIV-infected gay and bisexual men. The research has suggested the risk in this
population for developing depression is double that of other non-HIV-infected populations (both
heterosexual and homosexual). Further, due to the negative sequelae of depression on the
management of HIV infection, early detection and intervention are crucial. This study was
unable to determine a single best instrument to use for HIV-infected gay and bisexual men.
However, it was able to determine that inclusion of minority-specific variables (unstable
housing, lack of access to care, substance use) and control for somatic symptoms was effective in
the early detection of depression in HIV-infected gay and bisexual men. The clinical scales that
stood out the most include CGI, BSI-18, and the BDI.
Future research of this topic should delve further into understanding the efficacy of the
CGI, BSI-18, and BDI on this population. The research should include a broader scope of studies
with an aim focused on determining the best depression-seeking clinical tools for these persons.
Assessing variations within this population (i.e. HIV-infected gay and bisexual men who are
unstably housed versus HIV-infected gay and bisexual men who are IV drug users) would also
be of value. After obtaining a comprehensive screening instrument, researchers should explore
the best interventions to encourage positive health outcomes in HIV-infected gay and bisexual
men.
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Nurses are integral agents in the process of accessing health care, providing skills that are
vital to the detection of disruptions in both mental and physical health. Nurses perform
admission assessments, act as conduits to future inpatient and outpatient placements, provide
referrals to further specialized care, and can advocate for patient needs. Nurse researchers are
able to develop an evidence-base of best practices applicable to clinical settings. In regard to
detecting depression in HIV-infected gay and bisexual men, nurses are front line care providers.
They provide initial assessments and are able to devote the significant time to their patients. In
instances of encounters with HIV-infected gay and bisexual patients, nurses should include
depression screenings as routine care measures.
Future nursing research should focus on the development of an evidence-based tool to
influence best practices of care in HIV-infected gay and bisexual men, including those tools to
screen for depression in this high-risk population. Nurses in the clinical setting can use the best
appropriate comprehensive depression-screening instrument to determine if depression is an
active pathology in their HIV-infected gay and bisexual patients. This can help facilitate
improvement of the adherence to HAART, reduce transmission of HIV, increase the quality and
length of life, reduce risk-taking behaviors, protect against suicide, and reduce the sequelae of
both HIV and depression.
Nursing Education
Registered nurses and nurse practitioners often have limited exposure to issues relevant to
GLBT populations (Blackwell, 2015). As such, the experiences felt by nurses are not the same as
those of HIV-infected gay and bisexual men. Further, nurses are not exempt from displaying
behaviors described by attribution theory in that they may also ascribe blame to gay and bisexual
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men for their infection with HIV (Ramirez et. al, 2013). Ramirez and colleagues (2013) also
posit that the traditional health promotion strategy for HIV prevention of being personally
responsible for one’s health, such as using a condom or getting tested regularly, may be a
contributing factor to the societal development of homophobia. The lack of knowledge,
ascription of blame, and traditional health promotion model can be addressed through nursing
education.
Körner et. al (2008), provided surveys of general practitioners indicating depression in
HIV-infected gay and bisexual men was detected with more frequency when sexuality was
considered during initial assessments (Körner et. al, 2008). As homophobia and
heteronormativity are present in medical settings, research suggests providers should begin to
incorporate means to determine sexuality and provide interventions to counteract negative
outcomes (Körner et. al, 2008). Homophobia is a term that encompasses fear of and aversion to
homosexuality or homosexuals as well as discrimination and prejudice that accompanies
(Blackwell, 2015). Heteronormativity is described as “the attitude that heterosexuality is the only
normal and natural expression of sexuality” (Merriam-Webster, 2017) These ideas can be
relayed insidiously within healthcare settings by presuming all individuals are heterosexual and
ascribe to heterosexual relationships and marriage rather than asking openly about sexual
relationships with all genders (Blackwell, 2015).
Blackwell (2015) describes the need for education related to mental health in gay and
bisexual men as there is homophobia and persistent misunderstanding regarding the needs of this
population. Through incorporation of nursing curricula with an emphasis on gay and bisexual
men, nurses can develop better perspectives towards the experiences of gay and bisexual men
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and deeper understandings of their mental health needs (Blackwell, 2015). During health
promotion activities, nurses can tackle the current HIV-prevention model of personal
responsibility and push for a more empathetic message of collective responsibility, thus pulling
away from placing personal blame (Ramirez et, al, 2013). Lastly, nurses can provide a safe space
for HIV-infected gay and bisexual men to access health care through asking openly about sexual
practices and providing appropriate resources (Blackwell, 2015).
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Appendix A – Tables

Table 1: Table of Evidence
Inclusion Criteria: English-language, peer reviewed, evidence-based, abstract available, adult population, full-text available,
relevant to literature analysis
Exclusion Criteria: Pediatric population (<18 years old), not English-language, not relevant to literature analysis
Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Akena, D., Joska, J.,
Obuku, E. A., & Stein, D. J.
(2013). Sensitivity and
specificity of clinician
administered screening
instruments in detecting
depression among HIV
positive individuals in
Uganda. AIDS Care,
25(10), 1245-125.
doi:10.1080/09540121.2013
.764385

•

•

•

•

•

•

•

•

•

Mini International
Neuropsychiatric
Instrument (MINI) used
as gold standard
Patient Health
Questionnaire-9 (PHQ9)- AUC 0.964; CI of 0.920.99; optimal score of 10;
sensitivity 0.91; specificity
0.81
BEST performing
instrument of this study
PHQ-2 = shortened
version of PHQ-9; AUC
of 0.82; CI of 0.71-0.93;
optimal score of 3;
sensitivity 0.83; specificity
0.70
Centre for
Epidemiological Surveys
for Depression (CES-D)AUC of 0.944; CI 0.890.99; optimal score of 18;
sensitivity 0.88; specificity
0.81
Kessler-10 (K-10)- AUC
of 0.824; CI 0.72-0.93;

•
•

•

•

•

Coefficient 0.75 or
greater is adequate
BRIEF instruments may
be preferable in busy
areas
HIV positive patients
presented with MINI
defined depression in
HIV-primary care
clinics TWICE as often
as in non-HIV primary
health care settings
MINI confirmed
(w/sociodemographic
info) the high burden of
depression among
PLWHA in low/middle
income countries
All 3 instruments were
highly accurate in
ability to ID depression
r/t MINI
PHQ-9 validated
against the MINI had
very good psychometric
properties; however, the
shortened versions of
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•

•

HIV-positive
individuals
Population Size
= 368
-71% (261) were
women, mean
age = 31 (SD10);
n=241 employed;
lived within 21
km
-MINI defined
depression was
17.4%
Sample Size =
276

Uganda

•

•

Nurses (RN) were
able to successfully
administer the 3
questionnaires (PHQ9, K-10, and CES-D)
in a low/middleincome setting where
patients have low
literacy.
Having the ability to
screen at the level of
the RN provides
earlier detection of
depression and
greater access to
resources.
One of the roles of
nursing = patient
education. If
screening results in
positive markers of
depression; the nurse
should offer
education regarding
interventions and
expectations.

•

optimal score of 23;
sensitivity 0.83; specificity
0.72
K-6- shortened K-10;
AUC of 0.81; CI 0.710.93; optimal score of 13;
sensitivity 0.77; specificity
0.67

•

both questionnaires
were found to decrease
both sensitivity and
specificity of the results
K-10 did not perform as
well as the CES-D and
PHQ-9 probably b/c it
screens for
“psychological distress”
or “common mental
disorders” rather than
specifically depression
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Reference

Instrumentation

Outcomes

Population

Geographic
Location

Alciati, A., Gallo, L.,
Monforte, A.
D., Brambilla, F., &
Mellado, C.
(2007). Major depressionrelated
immunological changes and
combination antiretroviral
therapy in
HIV-seropositive patients.
Human
Psychopharmacology
Clinical &
Experimental, 22(1), 33-40.
doi:10.1002/hup.813

After MINI diagnosis 
interviewed w/:
1) Structured Clinical
Interview for DSM-IIIR/DSM-IV Axis I
disorders to confirm the
diagnosis
2) 17-Item Hamilton
Depression Rating Scale
(HDRS)- must score >20
to be selected
3) If negative HDRS screen,
participants selfadministered the Beck
Depression Inventory
(BDI)- if <4 and 0 on the
question “I do not feel sad”

•

•

•

•

•

•

•

Natural killer cells are
an appropriate marker
of the effect of
psychological disorders
(e.g. depression) on
immune functioning
Depressive symptoms
& stress (individual or
together) r/t decreased
NK and CD8 T-cells
MDD  functional
alterations of NK cells
(found in HIV+
women)
Improvement of
depression/symptoms
r/t increased NK cell
activity
After analyzing
different groups of
HIV-infected people
based on the form of
therapy they were
engaging in, the study
found: there is no form
of antiretroviral therapy
that will improve
diminished NK cell r/t
depression
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•

•
•
•
•

PLWHA
diagnosed with
major depression
per MINI
Non-depressed
PLWHA were
located and
matched with
criteria: gender,
age, r/f (i.e
IVDU or sexual
transmission),
1993 CDC HIV
staging, duration
of serostatus,
type/duration of
antiretroviral
therapies
N=113
n1=36 PLWHA
with MDD –
20M, 16F
n2=77 PLWHA
w/o MDD –
40M, 37F
EXCLUDED:
People who
learned of status
w/i last 6 mos.
-Significant
neuro/medical
illnesses
-Present/past IV
drug use, >60
alcoholic

Italy

Implications for HCPs &
Limitations
•

•

Aim of study was to
investigate MDD on
the immunological
function of PLWHA

This study shows
ARV therapy does
NOT improve
changes in NK cell
levels r/t MDD
• Limitation:
Low # of patients
Did not account for felt
stress (stress can account
for reduced immune
functioning)
• The nurse should
encourage continued
adherence to ARV
therapy while
stressing the
importance of
additionalsupportive- therapy
for MDD and
depressive symptoms

drinks/month,
heavy rec. drug
use
-Starting
antiretroviral
therapy <1
month ago
-Treatment
regimen with 2
NRTIs and 1
NNRTI
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Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Blank, M., Himelhoch, S.,
Balaji, A.,
Metzger, D., Dixon, L.,
Rose, C.,
Oraka, E., Davis-Vogel, A.,
Thompson, W.,
Heffelfinger, J.
(2014). A Multisite Study
of the
Prevalence of HIV with
Rapid
Testing in Mental Health
Settings.
American Journal of Public
Health,
104(12), 2377-2384.
doi:10.2105/

•

•

•

•

•

•

•

•

Short Form 12- Item
Health Survey (SF-12);
from the Medical
Outcomes Study
-Assess comprehensive
health status and
functioning
Risk Assessment Battery
(RAB)
-Assess sexual orientation,
homelessness/unstable
housing, involvement with
justice system,
type/frequency of drug
use, IDU (With source of
needles)
24-Item Behavior and
Symptom Identification
Scale (BASIS-24)
-6 subscale:
1) Depression/ functioning
2) Relationships
3) Self-harm
4) Emotional lability
5) Psychosis
6) Substance Abuse
-NOT diagnostic-specific
(e.g. depression only)
-Includes measures of a
broad range of symptoms
r/t mental illness
Algorithm to create 3
mutually exclusive
categories based on DSMIV diagnoses of psychiatric

•

•
•
•

•

•
•

•

Rate of infection was
higher in Baltimore
(5.9%) than
Philadelphia (3.9%)
288 = from universitybased inpatient psych
units; 17 were HIVinfected (5.9%)
273 = from ICM
programs; 14 were
HIV-infected (5.1%)
501 = CMHCs, 20 were
HIV-infected
Philadelphia:
24/608 tested positive;
21/24 previously knew
of status
Baltimore: 27/454
tested positive; 17/27
previously knew of
status
Age:
-40-49 had highest HIV
prevalence (6.7%)
Race:
-Black participants (692
people) had highest
HIV prevalence (6.2)
over other races
(White- 196 people;
other- 166 people)
Homeless/unstably
housed: 14/173 (8.1%)
people had HIV
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•
•
•

•

•

N=1061
621M, 436F
65.7% = Black
51 people=
confirmed HIV+
570 = ONLY
psychiatric
disorder
-332 (58.3%) had
schizophrenia or
other psychotic
disorder
-227 (59.4%) had
affective disorder
-11 (1.9%) had
other psych
diagnosis
350 = cooccurring psych
and substance
abuse disorders
141 = substance
abuse disorder
and no other
psych diagnoses

Baltimore
and
Philadelphi
a

•

•

•

•

•

•

Evaluation of patients
in this study occurred
over routine inpatient,
routine outpatient,
and intensive case
management mental
health settings
HIV = highly
prevalent in people
ALREADY receiving
mental health care
Patterns in HIV
infection are similar
to this population as
well: Black race,
homosexual/bisexual,
HCV infection, and
IVDU
Psychiatric severity
was DIRECTLY
associated with HIV
infection
HOWEVER –
prevalence of HIV
did not differ between
the 3 settings
Nurses should
implement continued
screening (using the
tested instruments)
and intervention in
HIV+ individuals
Nurses should
perform HIVscreening as part of

and substance abuse
disorders (commonly cooccur)
1) Psychiatric diagnosis only
2) Co-occurring psych and
substance
dependence/abuse
diagnoses
3) Those with substance
dependence/abuse
diagnosis only
• Colorado Symptom
Index for psychiatric
symptom severity
-47% increased r/f HIV
among people w/ scores
>30 (SEVERE psych
symptoms) – used in study
to show that more severe
psych symptoms = >
chance of being HIVinfected

•
•

•
•

•
•

Coinfection with HCV:
17/51 HIV-positive
people
10 of the 96-reported
homosexual or bisexual
individuals were HIV
positive
No statistical
significance for BASIS24
Emotional lability and
total RAB score were
significantly different
between HIV-infected
and non-HIV infected
populations
NO difference in
prevalence of HIV by
service setting
Need for long-term
caring relationships b/c
access to care in the
community for
PLWHA and mental
illness is diminished by:
substance abuse,
unstable housing, lack
of employment

23

•

baseline mental
health assessment
See article for some
“System-level
barriers” that must be
bridged in order for
HIV/MDD detection
to become
commonplace

Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Körner, H., Newman, C.,
Mao, L., Kippax, S., Kidd,
M., & Saltman, D. (2008).
'It's really a
myriad of
different signals, not just
the textbook': The
complexities of diagnosing
depression in gay men in
general practice. Mental
Health in Family
Medicine, 5, 167-175.

•

•

•

•

•

•

•

Face to face interviews
with HCPs
- Open-ended,
conversational
Explored diagnosis, tx,
management of depression
r/t HIV status, gender, and
sexuality
No instruments used to
diagnose depression in this
instance

•
•

•

Depression associated
with lower quality of
life, unemployment,
higher sexual risk
taking, non-adherence
to ARV treatment,
disease progression
Long-term, trusting
relationships with HCPs
resulted in better care
Major theme regarding
depression in HIVinfected gay men =
loss: income, careers,
relationships, family,
support, future…
Triggers to developing
depression, determined
by HCPs, = pos
diagnosis, starting ARV
therapy, AIDS defining
illness
- Long-term HIV
diagnosis and loss
of friend/loved-one
to disease =
MAJOR cause of
depression
- BE ALERT
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N = 16 HCPs
were interviewed
-14M, 2F
-Have worked in
HIV medicine
for 2-24 years

•
•

Sydney,
Australia
Adelaide,
Australia
A ruralcoastal
town in
Australia

•

•

•

General practitioners
in this study
considered all facets
of their patients’: life
circumstances, social
stigma r/t
homosexuality,
effects of HIV
epidemic (esp. as it
affects gay men
living with HIV for a
long time)
Being
homosexual/bisexual
is a major predictor
of suicidality
Unique challenges to
HCP; if depression is
1o to HIV = may/may
not have had hx of
depression; if
depression is 2o to
HIV- may be the
result of infection or
SE of ARV/txs
Complication unr/t to
limitations:
symptoms of
depression in
PLWHA are
sometimes hard to
detect b/c mimic
disease progression
- Fatigue, sleep
problems, weight

•

•

•

•

•

•
•
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loss
L: Diagnosis of
depression is affected
by demographic of
patients w/i primary
care setting
If pt. able to visit
more often, more
likely to have
symptoms recognized
Some HCPs may
meet resistance from
pt. in being labelled
“depressed”
L: Pt. may be
“depressed”
according to
standardized
instruments but not to
pt themselves
This study reinforces
the need to
DIRECTLY question
patients regarding
their mental health –
direct questioning
alleviates patient
fears about doubt and
discussion of
personal problems
Strengths:
HCPs understood
depression’s
prevalence in this
population, strong
commitment to
patients, proactively
pursued issues

Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Leserman, J. (2008). Role
of depression, stress, and
trauma in HIV disease
progression. Psychosomatic
Medicine, 70(5), 539-545.
doi:10.1097/PSY.0b013e31
81777a5f

•

•

•

•

•

•

CES-D (see Table 1 in
article)
-Findings at baseline:
decreased CD4 count,
increased mortality,
increased r/f AIDS
HDRS
- Findings at baseline:
increased r/f AIDS

•

SF Men’s Health
(N=400)
- Depressed at study
entry progressed to
AIDS 1.4 years sooner
than non-depressed
counterparts
- At 5.5 years, baseline
depression was r/t
CD4+ decline (did not
lead to AIDS/mortality)
- At 7 years – elevated
depressive symptoms =
67% increased r/f
mortality
M AIDS CS- Baseline
depression- before HIV
diagnosis- was not
associated with HIV
progression 8 years
after infection
- Increase in depression
6-18 months BEFORE
an AIDS diagnosis
- Re-analysis at 13
years indicated somatic
symptoms at baseline
associated with shorter
survival time BUT
NOT shorter time to
AIDS- opportunistic
disease
(fatigue, poor appetite,
trouble concentrating)
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•
•
•
•
•
•
•

San Francisco
Men’s Health
Study (9-year
longitudinal
study) – prior to
initiation of
HAART
N = 400
asymptomatic,
HIV+ gay men
Multicenter
AIDS Cohort
Study
N = 1339 gay
men
Longitudinal
study (8 years)
CHIP
N = 96
asymptomatic
HIV+ gay men
N = 85 HIV+
gay men
(Bereavement
section)

Literature
review out
of UNC
Chapel
Hill

•
•

•

•

•

•

When phrasing
questions on
depression scales,
using positively
worded items lead to
better predictions of
survival (i.e. hopeful
vs. sad)
Is depression a
predictor/result of
disease progression?
We must measure
depression as
baseline or measure
in the time interval
before HIV-related
changes to immune
status
Depression scores are
typically elevated in
the year before
AIDS-related death
Be aware of factors
that contribute to
depressive changes in
this population:
“Trauma” in the
sense of abuse,
assault, unexpected
death of loved one,
drug use,
abandonment
Bereavementparticularly in
individuals who have

•

•

•
•
•

•

•

Coping in Health and
Illness Project (CHIP) =
depressive symptoms
q6 months up to 9 years
In CHIP (N = 96)
- Each increase of 1
severe depressive
symptom = 2x r/f
AIDS at 5.5 years;
r/f clinical AIDS
condition (but not
AIDS) was 3x in 9
years
74% of participants
above median
progressed to AIDS
40% of participants
below median did not
Depression with
HAART use =
- > 5x r/f progression
to AIDS
- Slower suppression
of the virus
- Shorter survival
time
Cumulative depression
(w/ and w/o somatic
symptoms) =
progresson  AIDS,
nonadherence to meds,
decreased CD4 count,
and diminished
virological response
AIDS symptoms and
CD4 count do not
predict major
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•

•

•

•

•

•
•

lived with HIV for a
long time (partners
have passed, close
friends, they may be
very ill)
Finding meaning in
loss of loved ones,
less distress when
notified about change
in serostatus = slower
progression of HIV
Discontinuation of
HAART and nonadherence may lead
to depression (and
other health
outcomes)
PLWHA
seeking/receiving
mental health services
are <likely to die
from AIDS-related
causes
CBT and stress
management improve
depression, anxiety
and improve
adherence
Involve case
management; able to
provide psychiatric
resources, and refer
therapies
Limited by:
Our poor
understanding of the
biological mediators
for HIV infection

•

•

depression
Depressive symptoms
DO predict
development of AIDS
and other AIDS related
conditions
Bereavement section (N
= 85 gay men)
- Had a
partners/close
friends die of AIDS
- CD4 count rapidly
dropped during 3-4
years following
- Unexplained by
non-adherence or
health habits
- Did not show
progression to
AIDS or mortality
though
- Immune markers
associated with
increase r/f AIDS
(neopterin- immune
activation marker,
decreased NK cell
cytotoxicity and
lymphocyte
proliferative
response)
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•

Need for more
research into best
psychiatric therapies

Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Passos, S. M., Souza, L. D.,
& Spessato, B. C. (2014).
High prevalence of suicide
risk in people living with
HIV: who is at higher risk?
AIDS Care, 26(11), 13791382.
doi:10.1080/09540121.2014
.913767

•

•

•

•

•

•

•

MINI – Module C
- Assess suicide risk
- Module C = 5
questions regarding
previous 30 days and
questions suicide
attempts throughout
lifetime
Clinical interview:
- Time since diagnosis,
period on and current
use of ARV meds and
pt. perception of social
support r/t infection
Brazilian versions of:
- Alcohol, Smoking,
and Substance
Involvement
Screening Test
- Hospital Anxiety and
Depression Scale
(HAD)

•
•

•
•

•
•
•

Reinforces research
describing high
prevalence of suicide in
this population
compared to individuals
with other chronic
diseases
R/F: suicide increased
with length of diagnosis
n = 25 diagnosis < 12
months; n=10
determined at risk for
suicide (29.4%)
n = 141 diagnosis > 13
months; n = 41 at risk
for suicide/arfs (29.1%)
Stage of infection:
->Asymptomatic –
n=20; n=13 arfs
(44.8%)
->Symptomatic n=5; n=2 arfs
(40.0%)
->AIDS – n=177;
n=57 arfs (32.2%)
CD4 < 499; n=68, n=28
arfs (41.2%)
CD4 >500; n = 65,
n=19 arfs (29.2%)
Of the total sample: 49
patients (23.2%)
reported attempting
suicide at least once;
34.1% arfs
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•
•
•

N = 262
individuals with
HIV (>18 years
old)
101M, 110F
M, n = 24 at r/f
suicide
F, n = 48 at r/f
suicide

Pelotas,
Brazil

•

•
•

•

•

This study delves into
HIV+ individuals as a
whole (does not
differentiate gay/bi
men)
Consider:
stigma/demographics,
lack of support,
underlying mental
health disorders
(prior to diagnosis)
This population is at
very high risk for
suicide
Considering /rf:
HCPs should take
every effort to
implement
protective/preventativ
e measures
Routinely evaluate
HIV+ patients for
suicidality,
depression
Attend to social
support/inclusion,
unemployment, drug
use

Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Ramirez-Valles, J., Molina,
Y., & Dirkes, J. (2013).
Stigma towards PLWHA:
The role of internalized
homosexual stigma in
Latino Gay/Bisexual Male
and Transgender
communities. AIDS
Education & Prevention,
25(3), 179-189.
doi:10.1521/aeap.2013.25.3
.179

•

•

•

•

•

•

•

•

Internalized Homosexual
Stigma
17 item variable, validated
in this population “Being
gay means you will be
alone when old” (Likert
Scale)
- a= 0.88
HIV/AIDS Personal
Responsibility Beliefs
- 3 items; Likert Scale;
items capture existing
definitions of personal
responsibility in the
realm of HIV/AIDS –
the condition is the
result of people’s own
acts and values
- a = .66
Discriminatory Actions
Towards PLWHA
- Developed similarly to
PRB
- 3 items; Likert scale
- a = .70

•

•
•
•

•
•
•

•

Outcomes regarding
stigmatization of Latino
GBT individuals
Trans women included
b/c experiences of
stigmatization are
comparable to those of
G/B men
Discriminatory Actions
Towards PLWHA
> discriminatory actions
reported in Chicago
> discriminatory actions
reported by U.S.
residents than from
foreign born
Bisexual men >
discriminatory actions
than gay men
No difference by
serostatus
Discriminatory actions
towards PLWHA was
associated with both
HIV/AIDS Personal
Responsibility and
Internalized
Homosexual stigma.
It was found that there
is an empirical and
theoretical link between
homosexual stigma and
stigma towards
PLWHA in sexual
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•
•
•
•

•
•

643 gay, bisexual
men and trans
women (MF)
Chicago N = 320
San Francisco N
= 323
All Latino
individuals
Recruited by the
RespondentDriven Sampling
(RDS)
18-73 years old
170 (26.4%) =
HIV+

From
Chicago
and San
Francisco

•

•

•
•

•

Nurses/HCPs must
work to change the
message of
personality
responsibility to more
collective
responsibility and
empathy to others
Try to reduce the felt
exposure of stigma
against gay/bi men
and PLWHA
Important public
health problem as it
hinders prevention
efforts and negatively
affects health of
stigmatized people
Limited: cross
sectional vs
longitudinal or RCT
Study does not make
generalizations about
a population; but to
test a model about
attitudes towards
PLWHA (and how
they are shaped)
As internalized
stigma indicates
psychological distress
and lack of social
support HCPs should
consider addressing
those topics (perhaps

•

•

minorities
Latino GBT people
who have internalized
stigmatization project
onto PLWHA (see
HIV/AIDS as a
punishment)
Appears that the
message of personal
responsibility in the
prevention of
HIV/AIDS (use a
condom, get tested…)
contributes to a culture
of negative attitudes
towards PLWHA.
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refer to social
work/psych)

Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Sherr, L., Clucas, C.,
Harding, R.,
Sibley, E., &
Catalan, J. (2011,
October). HIV and
Depression- a
systematic review
of interventions.
Psychology, Health
& Medicine, 16(5),
493-527.

•

•

•

•

•

•

•
•
•
•

Beck Depression
Inventory (BDI)- a score
of 16 = “moderate” or
“severe” levels of
depressive symptoms;
cited 30/90 times
Centers for
Epidemiologic StudiesDepression Scale
(CES-D)- a score of 16 =
high level of depressive
symptoms; cited 19/90
times
Hamilton Depression
Rating Scale (HAM-D)- a
score of
Profile of Mood Statesdepression subscale
(POMS)- a score of
Clinical Global
Impression (CGI)
See Table III- Outcome
measures of depression

•

•

•

•

99 interventions were
investigated and
referred to =
psychological,
psychotropic,
psychosocial, physical,
HIV-specific health
psychology
Interventions
investigating effects of
treatment- on HIV and
its related conditionson depression found
these treatments
generally decrease
depression
- Enhancing efficacy
is a valuable area of
future research
The association btwn
elevated symptoms of
depression and disease
progression = a 1.7x
greater r/f mortality
than those without any
signs of elevated
depression
Depression may be a
cause of OR a marker
of disease progression
(as it has a complex
interaction in both)
Depression ca influence
immune function
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•
•
•

All HIV+
individuals; 90
articles included
out of 1015
65 studies
recruited only
men/mostly men
31 recruited
gay/bi men
21 standardized
instruments were
used

•
•
•
•
•
•
•
•
•
•
•
•
•
•

63 =
United
States
4=
Canada
2 = UK
3 = Spain
2 = Italy
1=
Belgium
2=
Germany
2 = HongKong
1 = Japan
2=
Netherland
s
1 = South
Africa
1=
Nigeria
1 = Kenya
1=
Tanzania
2 = Brazil

•

•

HCPs should
encourage patients to
routinely log
depression and
depressive symptoms
throughout the course
of infection with HIV
When utilizing any of
the depression
inventories it is vital
to control for somatic
symptoms by either:
excluding symptoms
or conducting
additional study into
the mental health of
the patient
Clearly demonstrates
the need to
incorporate regular
measurement/treatme
nt of depression in
this population

•

•
•

•

•

Depression can be the
consequence of disease
progression or negative
life/disease events 
trigger lower mood
reactions
HIV+ people = 1.99x
more likely to have
MDD than HIV- people
Depression can emerge
due to triggers during
the progression of HIV
(emotional reactions,
chronic stress from
social stigma, long-term
physical discomfort)
Depression predicts
quality of life better
then severity in the
stages of HIV/AIDS
5/9 HIV-specific health
psychology
interventions appear
effective (55.5%)
- Risk
prevention/reductio
n interventions
- Adherence to ART
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Reference

Instrumentation

Outcomes

Population

Geographic
Location

Implications for HCPs &
Limitations

Sivasubramanian, M.,
Mimiaga, M. J., Mayer, K.
H., Anand, V. R., Johnson,
C. V., Prabhugate,
P., & Safren, S. A.
(2011). Suicidality, clinical
depression, and anxiety
disorders are highly
prevalent in men who have
sex with men in Mumbai,
India: Findings from a
community-recruited
sample. Psychology, Health
& Medicine, 16(4), 450-462

•

•

•

•

•

•

•

Mini International
Neuropsychiatric Interview
(MINI)
- Cited in article
- Validated, brief
- English-language
translated into Hindi
for this study
- Assesses psych
disorders including
MDD
- Assessed outcomes:
1) Current suicidality
2) Current MDD
3) Screen for any
anxiety related
disorder
Brief Symptom Inventory18 (BSI-18)
- Validated in
community
populations
- Screens for psych
distress, anxiety,
depression, and
somatization
Rosenberg Self-Esteem
Study
- Validated tool to
determine self-esteem
of participants
- Total score = 36
- Likert scale questions
of 1-4

•
•

•

•

India = highest # of
HIV infections in Asia
and 3rd largest epidemic
in the world
MSM = highest risk
group with increasing
risk/prevalence
It is known that MSM
experience worsened
mental health in greater
numbers in western
nations such as US
Minority stress = model
that explains health
disparities in MSM and
other sexual minorities
- Evaluates external
social conditions
(i.e. stigma,
discrimination,
prejudice)
- Evaluates internal
conditions such as
expectation of
rejection,
internalized
homophobia
- ^ presents as
depression, anxiety,
SI
Syndemics occur where
mental health problems
+ HIV = increased r/f
transmission/progressio
n of disease
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•

N = 150 M
(MSM= men
who have sex
with men; gay/bi
men – does not
include Trans
men)
- Mean age =
25.1 yo
- 21% married
to women
- 24% =
current
MDD
- 45% current
suicidal
ideation
- 15% = high
r/f suicide
- 19% =
moderate r/f
suicide
- 66% = low
risk
References a
second study in
Chennai with
210 MSM
- Over ½ of
study had
“significant
depressive
symptoms”
associated
with

Mumbai,
India

•

•

•

•

This population is
MORE likely to be
HIV+ than the rest of
the population
Programs to improve
self-esteem, support
networks may
improve mental
health outcomes
HCPs should
absolutely
incorporate mental
health
services/referrals into
practice
Because of pressure
to remain hidden,
finding sexual
partners can be
difficult and may
increase high-risk
behaviors (such as
negotiating safe sex)
– reinforce the need
to continue safe
sexual practices
Same-sex behavior is
technically criminal
in Indian states (other
areas of the world);
culturally; forbidden
 increased r/f
mental health
disorders (reinforces
need for screening

•

•

Life Experiences Survey
- Assess 40 stressful life
events over past 6
months
- Includes:
1) Pressure of
marriage
2) Pressure of have
children
3) Fear of having
orientation
discovered
4) Discrimination
5) Harassment
- 5 Most Common:
1) Financial
problems
2) Anxiety/guilt
about sex life
3) Fear of having
sexual orientation
known
4) Work pressure
5) Other
- However, 12 =
average number of
stressful life events
reported
For study, 1 time
confidential quantitative
interview conducted (nonexperimental descriptive
study) through the
Humsafar Trust (in
Mumbai, India)
- Included: 18-50 yo
MSM
- MSM defined as:

•

Self-esteem and
perception of social
support play roles in
protecting from suicide,
MDD, and other psych
disorders
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unprotected
anal sex and
increased #
of male
sexual
partners

and
referrals/interventions

-

-Kothi – feminine
acting/appearing/recep
tive partner
-Panthi –
masculine/insertiv
-Gay or bi men
-Other term
MF trans women
were no included b/c
they have different life
experiences (called
hijra, ali, or arivani)
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Appendix B - Figures

Figure 1: Flow Diagram of Article Selection Process
Key Search Terms - HIV, AIDS, immun*, “HIV and infection”, depress*, “depressive
disorders”, instrument*, bisexual, homosexual, gay, man, men, male*, “HIV seropositivity”, and
HAART
Limiters - English language, evidence-based practice, peer-reviewed, and use of research
instruments, questionnaires, or scales
Databases used: CINAHL Plus with Full Text, MEDLINE, PsychINFO, and Heath and Psychosocial Instruments
(MH "HIV-Infected Patients") OR (MH "Treatment Refusal") OR (MH "HIV Seropositivity") OR (MH “HIV
Integrase Inhibitors") OR (MH "HIV treatment") AND HAART
This search yielded 400 articles
(N = 400)

Databases used: CINAHL Plus with Full Text, MEDLINE, PsychINFO, and Heath and Psychosocial Instruments
(MH "Human Immunodeficiency Virus") OR HIV OR "HIV-infected patient" OR HIV/AIDs OR "Human
Immunodeficiency Virus") AND (anxiety or depress*) AND (men or male) AND (stigma* or shame or ridicule or
prejudice* or stereotype*) AND instrument*
This search yielded 195 articles
(N = 195)
Upon review of these articles, abstracts, and research aims, the number of accepted results was further reduced
to 88 articles
(N = 88)
88 final articles were hand reviewed for
relevance
(N = 88)

56 articles excluded after not fully meeting inclusion criteria, resulting in
42 remaining articles
(N = 42)

A final, more detailed review was performed resulting in the exclusion of
more articles for not fully pertaining to the aims of this study
15 articles remained for inclusion in this analysis
(N = 15)
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